209 related articles for article (PubMed ID: 30596709)
21. Tulathromycin: an overview of a new triamilide antibiotic for livestock respiratory disease.
Evans NA
Vet Ther; 2005; 6(2):83-95. PubMed ID: 16094557
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of tulathromycin in plasma and milk samples after a single subcutaneous injection in lactating goats (Capra hircus).
Grismer B; Rowe JD; Carlson J; Wetzlich SE; Tell LA
J Vet Pharmacol Ther; 2014 Apr; 37(2):205-8. PubMed ID: 23889045
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic/pharmacodynamic evaluation of marbofloxacin in the treatment of Haemophilus parasuis and Actinobacillus pleuropneumoniae infections in nursery and fattener pigs using Monte Carlo simulations.
Vilalta C; Giboin H; Schneider M; El Garch F; Fraile L
J Vet Pharmacol Ther; 2014 Dec; 37(6):542-9. PubMed ID: 24903473
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary pharmacokinetics of tulathromycin in swine. Part 2: Intra-airways compartments.
Villarino N; Lesman S; Fielder A; García-Tapia D; Cox S; Lucas M; Robinson J; Brown SA; Martín-Jiménez T
J Vet Pharmacol Ther; 2013 Aug; 36(4):340-9. PubMed ID: 23067107
[TBL] [Abstract][Full Text] [Related]
25. Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
Blondeau JM; Fitch SD
PLoS One; 2019; 14(1):e0210154. PubMed ID: 30629633
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and lung and muscle concentrations of tulathromycin following subcutaneous administration in white-tailed deer (Odocoileus virginianus).
Bachtold KA; Alcorn JM; Boison JO; Matus JL; Woodbury MR
J Vet Pharmacol Ther; 2016 Jun; 39(3):292-8. PubMed ID: 26669905
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of tulathromycin and its metabolite in swine administered with an intravenous bolus injection and a single gavage.
Wang X; Tao YF; Huang LL; Chen DM; Yin SZ; Ihsan A; Zhou W; Su SJ; Liu ZL; Pan YH; Yuan ZH
J Vet Pharmacol Ther; 2012 Jun; 35(3):282-9. PubMed ID: 21749408
[TBL] [Abstract][Full Text] [Related]
28. Formulation of a rational dosage regimen of ceftiofur hydrochloride oily suspension by pharmacokinetic-pharmacodynamic (PK-PD) model for treatment of swine
Luo W; Wang D; Qin H; Chen D; Pan Y; Qu W; Huang L; Xie S
J Vet Sci; 2021 Nov; 22(6):e41. PubMed ID: 34854264
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of pharmacokinetic/pharmacodynamic relationships of PD-0162819, a biotin carboxylase inhibitor representing a new class of antibacterial compounds, using in vitro infection models.
Ogden A; Kuhn M; Dority M; Buist S; Mehrens S; Zhu T; Xiao D; Miller JR; Hanna D
Antimicrob Agents Chemother; 2012 Jan; 56(1):124-9. PubMed ID: 21986824
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial susceptibility patterns and sensitivity to tulathromycin in goat respiratory bacterial isolates.
Clothier KA; Kinyon JM; Griffith RW
Vet Microbiol; 2012 Apr; 156(1-2):178-82. PubMed ID: 22078276
[TBL] [Abstract][Full Text] [Related]
31. Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China.
Mi K; Sun D; Li M; Hao H; Zhou K; Liu Z; Yuan Z; Huang L
Pathogens; 2021 Jan; 10(2):. PubMed ID: 33498972
[No Abstract] [Full Text] [Related]
32. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
Huang L; Zhang H; Li M; Ahmad I; Wang Y; Yuan Z
BMC Vet Res; 2018 Oct; 14(1):319. PubMed ID: 30355326
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of tulathromycin after single and multiple subcutaneous injections in domestic goats (Capra aegagrus hircus).
Clothier KA; Leavens T; Griffith RW; Wetzlich SE; Baynes RE; Riviere JE; Tell LA
J Vet Pharmacol Ther; 2011 Oct; 34(5):448-54. PubMed ID: 21366621
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial resistance genes in Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida isolated from Australian pigs.
Dayao D; Gibson JS; Blackall PJ; Turni C
Aust Vet J; 2016 Jul; 94(7):227-31. PubMed ID: 27349882
[TBL] [Abstract][Full Text] [Related]
35. Effects of experimentally induced respiratory disease on the pharmacokinetics and tissue residues of tulathromycin in meat goats.
Smith JS; Mochel JP; Borts DJ; Griffith RW
J Vet Pharmacol Ther; 2019 Jul; 42(4):420-429. PubMed ID: 31183876
[TBL] [Abstract][Full Text] [Related]
36. Effect of marbofloxacin on Haemophilus parasuis nasal carriage.
Vilalta C; Galofré N; Aragon V; Pérez de Rozas AM; Fraile L
Vet Microbiol; 2012 Sep; 159(1-2):123-9. PubMed ID: 22487455
[TBL] [Abstract][Full Text] [Related]
37. iTRAQ-based quantitative proteomic analysis reveals multiple effects of Emodin to Haemophilus parasuis.
Li L; Tian Y; Yu J; Song X; Jia R; Cui Q; Tong W; Zou Y; Li L; Yin L; Liang X; He C; Yue G; Ye G; Zhao L; Shi F; Lv C; Cao S; Yin Z
J Proteomics; 2017 Aug; 166():39-47. PubMed ID: 28679110
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine.
Benchaoui HA; Nowakowski M; Sherington J; Rowan TG; Sunderland SJ
J Vet Pharmacol Ther; 2004 Aug; 27(4):203-10. PubMed ID: 15305848
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of tulathromycin after subcutaneous injection in North American bison (Bison bison).
Bachtold K; Alcorn J; Matus J; Boison J; Woodbury M
J Vet Pharmacol Ther; 2015 Oct; 38(5):471-4. PubMed ID: 25772094
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary pharmacokinetics of tulathromycin in swine. Part I: Lung homogenate in healthy pigs and pigs challenged intratracheally with lipopolysaccharide of Escherichia coli.
Villarino N; Lesman S; Fielder A; García-Tapia D; Cox S; Lucas M; Robinson J; Brown SA; Martín-Jiménez T
J Vet Pharmacol Ther; 2013 Aug; 36(4):329-39. PubMed ID: 23072251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
